Condition: Arthroplasty · Replacement · Shoulder · Sponsor: Limacorporate S.p.a
This clinical study aims at evaluating clinical, radiographic and patient-reported outcomes after total anatomic or reverse shoulder replacement using PRIMA humeral stem up to 24 months after surgery, in order to assess the short-term performance of the implant. Furthermore, the objective is also to collect short-term data on the survivorship of the implant and the incidence of complications.
This description comes directly from the study's public registry record.
Camilla Vianello · +390432945357 · camilla.vianello@limacorporate.com
Francesca Citossi · +390432945357 · francesca.citossi@limacorporate.com
Always discuss trial participation with your own doctor first.
| Unit of Shoulder Surgery Romagna/ Cervesi Hospital, Italy | Cattolica, Rimini, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06371833